SymBio Pharmaceuticals Limited (4582.T) JPX

73.00

-1(-1.35%)

Updated at June 03 03:23PM

Currency In JPY

Valuation

Market Cap4.52B
Enterprise Value3.62B
P/E Ratio-0.83
PEG Ratio0.07
Price/Sales Ratio3.15
Price/Book Ratio21.08
Enterprise/Revenue2.47
Enterprise/EBITDA-0.55

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-4.59
Operating Margin-4.39

Management Effectiveness

Return On Assets-1.99
Return On Equity-4.24

Income Statement

Revenue1.31B
Revenue/Share19.09
Gross Profit947.34M
EBITDA-4.6B
Net Income-4.78B
Diluted EPS-95.12

Balance Sheet

Total Cash1.9B
Total Cash/Share28.36
Total Debt1.03B
Total Debt/Equity4.43
Current Ratio1.11
Book Value Per Share3.46

Price History

52-Week Change-56.55
52-Week High229
52-Week Low71
Moving Average 50 Days94.02
Moving Average 200 Days111.21

Statistics

Average Volume2.75M
Shares Outstanding55.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJune 26, 2019